Silvia La Marca

657 total citations
25 papers, 416 citations indexed

About

Silvia La Marca is a scholar working on Hematology, Surgery and Internal Medicine. According to data from OpenAlex, Silvia La Marca has authored 25 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 8 papers in Surgery and 4 papers in Internal Medicine. Recurrent topics in Silvia La Marca's work include Platelet Disorders and Treatments (17 papers), Blood groups and transfusion (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Silvia La Marca is often cited by papers focused on Platelet Disorders and Treatments (17 papers), Blood groups and transfusion (10 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (6 papers). Silvia La Marca collaborates with scholars based in Italy, United States and France. Silvia La Marca's co-authors include Augusto B. Federici, Francesca Stufano, Luciano Baronciani, Pier Mannuccio Mannucci, Flora Peyvandi, Robert W. Dunn, Alberto Tosetto, Francesco Rodeghiero, Giancarlo Castaman and G. Eulisse and has published in prestigious journals such as Blood, Life Sciences and Psychopharmacology.

In The Last Decade

Silvia La Marca

23 papers receiving 408 citations

Peers

Silvia La Marca
Melissa J. Rose United States
Nicholas A. Dewyer United States
Sean M. Cullen United States
Miranda C. Marion United States
Krista Kuitwaard Netherlands
Silvia La Marca
Citations per year, relative to Silvia La Marca Silvia La Marca (= 1×) peers Gaurav Tyagi

Countries citing papers authored by Silvia La Marca

Since Specialization
Citations

This map shows the geographic impact of Silvia La Marca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia La Marca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia La Marca more than expected).

Fields of papers citing papers by Silvia La Marca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia La Marca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia La Marca. The network helps show where Silvia La Marca may publish in the future.

Co-authorship network of co-authors of Silvia La Marca

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia La Marca. A scholar is included among the top collaborators of Silvia La Marca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia La Marca. Silvia La Marca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lecchi, Anna, Giulia Tosetti, Silvia La Marca, et al.. (2024). Comprehensive investigation of platelet function in patients with cirrhosis. Thrombosis Research. 237. 64–70. 2 indexed citations
2.
Suffritti, Chiara, Roberta Gualtierotti, Alessandro Ciavarella, et al.. (2023). Characterization of Immunogenicity and Safety of COVID-19 mRNA-1273 in HIV-Positive Italian Patients with Hemophilia: A Prospective Single-Center Cohort Study. Journal of Clinical Medicine. 12(17). 5475–5475.
3.
Bonato, Sara, Andrea Artoni, Anna Lecchi, et al.. (2021). Massive cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia. Haematologica. 106(11). 3021–3024. 8 indexed citations
4.
Panigada, Mauro, Stefano Ghirardello, Anna Lecchi, et al.. (2021). Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study. Thrombosis and Haemostasis. 121(8). 1087–1096. 7 indexed citations
5.
Rossi, Paolo, Ramona Cassin, Anna Lecchi, et al.. (2021). Acquired hemophilia A and delta storage pool deficiency in a patient with indolent non-Hodgkin lymphoma. Platelets. 33(1). 168–170.
6.
Gorski, Marcin M., Anna Lecchi, Eti Alessandra Femia, et al.. (2019). Complications of whole-exome sequencing for causal gene discovery in primary platelet secretion defects. Haematologica. 104(10). 2084–2090. 10 indexed citations
7.
Lecchi, Anna, Silvia La Marca, Eti Alessandra Femia, et al.. (2019). Novel variant in HPS3 gene in a patient with Hermansky Pudlak syndrome (HPS) type 3. Platelets. 31(7). 960–963. 3 indexed citations
8.
Artoni, Andrea, Maria Abbattista, Barbara Marinelli, et al.. (2018). Hemostatic abnormalities in patients with Ehlers–Danlos syndrome. Journal of Thrombosis and Haemostasis. 16(12). 2425–2431. 25 indexed citations
9.
Bucciarelli, Paolo, Simona Maria Siboni, Francesca Stufano, et al.. (2014). Predictors of von Willebrand disease diagnosis in individuals with borderline von Willebrand factor plasma levels. Journal of Thrombosis and Haemostasis. 13(2). 228–236. 14 indexed citations
10.
Pagliari, M, Luciano Baronciani, Silvia La Marca, et al.. (2013). A synonymous (c.3390C>T) or a splice‐site (c.3380‐2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE). Journal of Thrombosis and Haemostasis. 11(7). 1251–1259. 14 indexed citations
11.
Stufano, Francesca, et al.. (2013). A two‐centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen. Haemophilia. 20(1). 147–153. 35 indexed citations
12.
Baronciani, Luciano, Silvia La Marca, Giovanna Cozzi, et al.. (2012). Molecular characterization, recombinant protein expression, and mRNA analysis of type 3 von Willebrand disease: Studies of an Italian cohort of 10 patients. American Journal of Hematology. 87(9). 870–874. 7 indexed citations
13.
Castaman, Giancarlo, Augusto B. Federici, Alberto Tosetto, et al.. (2012). Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients. Journal of Thrombosis and Haemostasis. 10(4). 632–638. 92 indexed citations
14.
Gritti, Giuseppe, Agostino Cortelezzi, Paolo Bucciarelli, et al.. (2011). Circulating and progenitor endothelial cells are abnormal in patients with different types of von Willebrand disease and correlate with markers of angiogenesis. American Journal of Hematology. 86(8). 650–656. 20 indexed citations
15.
Nurden, Paquita, Giuliana Gobbi, Alan T. Nurden, et al.. (2010). Abnormal VWF modifies megakaryocytopoiesis: studies of platelets and megakaryocyte cultures from patients with von Willebrand disease type 2B. Blood. 115(13). 2649–2656. 54 indexed citations
16.
Baronciani, Luciano, Augusto B. Federici, Giovanna Cozzi, et al.. (2009). Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization. Journal of Thrombosis and Haemostasis. 7(7). 1114–1122. 13 indexed citations
17.
Baronciani, Luciano, Augusto B. Federici, Giovanna Cozzi, et al.. (2008). Expression studies of missense mutations p.D141Y, p.C275S located in the propeptide of von Willebrand factor in patients with type 3 von Willebrand disease. Haemophilia. 14(3). 549–555. 19 indexed citations
18.
Caccialanza, M., Silvia La Marca, R. Piccinno, & G. Eulisse. (2007). Radiotherapy of classic and human immunodeficiency virus‐related Kaposi's sarcoma: results in 1482 lesions. Journal of the European Academy of Dermatology and Venereology. 22(3). 297–302. 45 indexed citations
20.
Marca, Silvia La, et al.. (1994). Single versus multiple infusions of fentanyl analogues in a rat EEG model. Life Sciences. 55(17). 1337–1342. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026